These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11383981)

  • 21. Augmentation of lithium's behavioral effect by inositol uptake inhibitors.
    Einat H; Kofman O; Itkin O; Lewitan RJ; Belmaker RH
    J Neural Transm (Vienna); 1998; 105(1):31-8. PubMed ID: 9588758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.
    Parthasarathy LK; Seelan RS; Wilson MA; Vadnal RE; Parthasarathy RN
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):55-60. PubMed ID: 12551726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities.
    Kopnisky KL; Chalecka-Franaszek E; Gonzalez-Zulueta M; Chuang DM
    Neuroscience; 2003; 116(2):425-35. PubMed ID: 12559097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
    Malhi GS; Outhred T
    CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase activities: a novel target of lithium therapy.
    Patel S; Yenush L; Rodríguez PL; Serrano R; Blundell TL
    J Mol Biol; 2002 Jan; 315(4):677-85. PubMed ID: 11812139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen synthesis in brain and astrocytes is inhibited by chronic lithium treatment.
    Souza Ade A; da Silva GS; Velez BS; Santoro AB; Montero-Lomelí M
    Neurosci Lett; 2010 Sep; 482(2):128-32. PubMed ID: 20637832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the functions of lithium: the mood stabilizer.
    Shastry BS
    Bioessays; 1997 Mar; 19(3):199-200. PubMed ID: 9103188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamate-mediated calcium signaling: a potential target for lithium action.
    Sourial-Bassillious N; Rydelius PA; Aperia A; Aizman O
    Neuroscience; 2009 Jul; 161(4):1126-34. PubMed ID: 19362133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular effects of lithium.
    Quiroz JA; Gould TD; Manji HK
    Mol Interv; 2004 Oct; 4(5):259-72. PubMed ID: 15471909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex.
    Brandish PE; Su M; Holder DJ; Hodor P; Szumiloski J; Kleinhanz RR; Forbes JE; McWhorter ME; Duenwald SJ; Parrish ML; Na S; Liu Y; Phillips RL; Renger JJ; Sankaranarayanan S; Simon AJ; Scolnick EM
    Neuron; 2005 Mar; 45(6):861-72. PubMed ID: 15797548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium suppresses signaling and induces rapid sequestration of beta2-adrenergic receptors.
    Doronin S; Shumay E; Wang HY; Malbon CC
    Biochem Biophys Res Commun; 2001 Oct; 288(1):151-5. PubMed ID: 11594766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Search for a common mechanism of mood stabilizers.
    Harwood AJ; Agam G
    Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo.
    Yuan P; Chen G; Manji HK
    J Neurochem; 1999 Dec; 73(6):2299-309. PubMed ID: 10582587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lithium ion: a foundation for psychopharmacological specificity.
    Soares JC; Gershon S
    Neuropsychopharmacology; 1998 Sep; 19(3):167-82. PubMed ID: 9653704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
    Ryves WJ; Harwood AJ
    Biochem Biophys Res Commun; 2001 Jan; 280(3):720-5. PubMed ID: 11162580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inositol, lithium, and the brain.
    Agranoff BW; Fisher SK
    Psychopharmacol Bull; 2001; 35(3):5-18. PubMed ID: 12397875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of lithium pharmacology through manipulation of phosphoadenosine phosphate metabolism.
    Spiegelberg BD; Dela Cruz J; Law TH; York JD
    J Biol Chem; 2005 Feb; 280(7):5400-5. PubMed ID: 15583009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium inhibitable enzymes in postmortem brain of bipolar patients.
    Agam G; Shaltiel G; Kozlovsky N; Shimon H; Belmaker RH
    J Psychiatr Res; 2003; 37(5):433-42. PubMed ID: 12849935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors.
    Gould TD; Einat H; O'Donnell KC; Picchini AM; Schloesser RJ; Manji HK
    Neuropsychopharmacology; 2007 Oct; 32(10):2173-83. PubMed ID: 17299510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?
    Rapoport SI; Bosetti F
    Arch Gen Psychiatry; 2002 Jul; 59(7):592-6. PubMed ID: 12090811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.